The extension of indications for the implantation of Ahmed valve

Vadim P. Nikolaenko , Vladimir V. Brzheskiy , Аnastasiia V. Аntonova

Ophthalmology Reports ›› 2023, Vol. 16 ›› Issue (2) : 83 -90.

PDF
Ophthalmology Reports ›› 2023, Vol. 16 ›› Issue (2) : 83 -90. DOI: 10.17816/OV340821
Discussions
research-article

The extension of indications for the implantation of Ahmed valve

Author information +
History +
PDF

Abstract

In contrast to the Ahmed valve implantation technique and solutions of possible problems associated with its implantation, the available literature does not clearly state the indications for the choice of classical glaucoma filtering surgery (especially for primary open-angle glaucoma) and of a valve hypotensive device. This publication aims to fill this gap.

Keywords

glaucoma / trabeculectomy / Ahmed valve implantation / ocular surface / dry eye syndrome / preservative load / indications for surgery / perioperative treatment

Cite this article

Download citation ▾
Vadim P. Nikolaenko, Vladimir V. Brzheskiy, Аnastasiia V. Аntonova. The extension of indications for the implantation of Ahmed valve. Ophthalmology Reports, 2023, 16(2): 83-90 DOI:10.17816/OV340821

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Avo-portal.ru [Internet]. Klinicheskie rekomendatsii. Glaukoma pervichnaya otkrytougol’naya. 2020 [cited: 2023 Mar 26]. Available ay: http://avo-portal.ru/doc/fkr/item/246-glaukoma-otkrytougolnay (In Russ.)

[2]

Avo-portal.ru [Электронный ресурс]. Клинические рекомендации. Глаукома первичная открытоугольная. 2020 [дата обращения: 26.03.2023]. Доступ по: http://avo-portal.ru/doc/fkr/item/246-glaukoma-otkrytougolnay

[3]

Egorov EA, Erichev VP, editors. Natsional’noe rukovodstvo po glaukome dlya praktikuyushchikh vrachei. Moscow: GEOTAR-Media, 2019. 384 p. (In Russ.) DOI: 10.33029/9704-5442-8-GLA-2020-1-384

[4]

Национальное руководство по глаукоме для практикующих врачей / под ред. Е.А. Егорова, В.П. Еричева. Москва: ГЭОТАР-Медиа, 2019. 384 с. DOI: 10.33029/9704-5442-8-GLA-2020-1-384

[5]

Bikbov MM, Khusnitdinov II. Ahmed valve in glaucoma surgery. The Russian Annals of Ophthalmology. 2017;133(6):126310. (In Russ.) DOI: 10.17116/oftalma20171336126-130

[6]

Бикбов М.М., Хуснитдинов И.И. Клапан Ахмеда в хирургии глаукомы // Вестник офтальмологии. 2017. T. 133, № 6. С. 126–310. DOI: 10.17116/oftalma20171336126-130

[7]

European Glaucoma Society Terminology and Guidelines for Glaucoma, 5. Savona: PubliComm, 2020.

[8]

Tan HB, Kang X, Lu SH, Liu L. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. PLoS ONE. 2015;10(2):e0118142. DOI: 10.1371/journal.pone.0118142

[9]

Tan H.B., Kang X., Lu S.H., Liu L. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis // PLoS ONE. 2015. Vol. 10, No. 2. ID e0118142. DOI: 10.1371/journal.pone.0118142

[10]

Luzu J, Baudouin C, Hamard P. The role of Ahmed glaucoma valve in the management of refractory glaucoma: Long-term outcomes and complications. Eur J Ophthalmol. 2021;31(5):2383–2389. DOI: 10.1177/1120672120968733

[11]

Luzu J., Baudouin C., Hamard P. The role of Ahmed glaucoma valve in the management of refractory glaucoma: Long-term outcomes and complications // Eur J Ophthalmol. 2021. Vol. 31, No. 5. P. 2383–2389. DOI: 10.1177/1120672120968733

[12]

Posareli C, Toro MD, Rejdak R, et al. Safety and efficacy of second Ahmed valve implant in refractory glaucoma. J Clin Med. 2020;9(7):2039. DOI: 10.3390/jcm9072039

[13]

Posareli C., Toro M.D., Rejdak R., et al. Safety and efficacy of second Ahmed valve implant in refractory glaucoma // J Clin Med. 2020. Vol. 9, No. 7. ID2039. DOI: 10.3390/jcm9072039

[14]

Pimentel E, Schmidt J. Is Ahmed valve superior to Baerveldt implant as an aqueous shunt for the treatment of glaucoma? Medwave. 2018;18(5): e7239. DOI: 10.5867/medwave.2018.05.7238

[15]

Pimentel E., Schmidt J. Is Ahmed valve superior to Baerveldt implant as an aqueous shunt for the treatment of glaucoma? // Medwave. 2018. Vol. 18, No. 5. ID e7239. DOI: 10.5867/medwave.2018.05.7238

[16]

Nardi M, Maglionico MN, Posarelli C, Figus M. Managing Ahmed Glaucoma Valve tube exposure: Surgical technique. Eur J Ophthalmol. 2021;31(2):778–781. DOI: 10.1177/1120672120925641

[17]

Nardi M., Maglionico M.N., Posarelli C., Figus M. Managing Ahmed Glaucoma Valve tube exposure: Surgical technique // Eur J Ophthalmol. 2021. Vol. 31, No. 2. P. 778–781. DOI: 10.1177/1120672120925641

[18]

Riva I, Roberti G, Oddone F, et al. Ahmed glaucoma valve implant: surgical technique and complications. Clin Ophthalmol. 2017;11: 357–367. DOI: 10.2147/OPTH.S104220

[19]

Riva I., Roberti G., Oddone F., et al. Ahmed glaucoma valve implant: surgical technique and complications // Clin Ophthalmol. 2017. Vol. 11. P. 357–367. DOI: 10.2147/OPTH.S104220

[20]

Lee CK, Ma KT, Hong YJ, Chan YK. Long-term clinical outcomes of Ahmed valve implantation in patients with refractory glaucoma. PLoS ONE. 2017;12(11): e0187533. DOI: 10.1371/journal.pone.0187533

[21]

Lee C.K., Ma K.T., Hong Y.J., Chan Y.K. Long-term clinical outcomes of Ahmed valve implantation in patients with refractory glaucoma // PLoS ONE. 2017. Vol. 12, No. 11. ID e0187533. DOI: 10.1371/journal.pone.0187533

[22]

Riva I, Roberti G, Katsanos A, et al. A review of the Ahmed Glaucoma Valve implant and comparison with other surgical operations. Adv Ther. 2017;34(4):834–847. DOI: 10.1007/s12325-017-0503-1

[23]

Riva I., Roberti G., Katsanos A., et al. A review of the Ahmed Glaucoma Valve implant and comparison with other surgical operations // Adv Ther. 2017. Vol. 34, No. 4. P. 834–847. DOI: 10.1007/s12325-017-0503-1

[24]

Wagdy FM. Tenon capsule grafting versus autologous scleral graft in Ahmed Glaucoma Valve surgery. J Ophthalmol. 2020;2020:1248023. DOI: 10.1155/2020/1248023

[25]

Wagdy F.M. Tenon capsule grafting versus autologous scleral graft in Ahmed Glaucoma Valve surgery // J Ophthalmol. 2020. Vol. 2020. ID 1248023. DOI: 10.1155/2020/1248023

[26]

Rotsos T, Tsioga A, Andreanos K, et al. Managing high risk glaucoma with the Ahmed valve implant: 20 years of experience. Int J Ophthalmol. 2018;11(2):240–244. DOI: 10.18240/ijo.2018.02.10

[27]

Rotsos T., Tsioga A., Andreanos K., et al. Managing high risk glaucoma with the Ahmed valve implant: 20 years of experience // Int J Ophthalmol. 2018. Vol. 11, No. 2. P. 240–244. DOI: 10.18240/ijo.2018.02.10

[28]

Lee HM, Park KS, Jeon YY, et al. Clinical outcomes of Ahmed glaucoma valve implantation without fixation of a plate: The free plate technique. PLoS ONE. 2020;15(11): e0241886. DOI: 10.1371/journal.pone.0241886

[29]

Lee H.M., Park K.S., Jeon Y.Y., et al. Clinical outcomes of Ahmed glaucoma valve implantation without fixation of a plate: The free plate technique // PLoS ONE. 2020. Vol. 15, No. 11. ID e0241886. DOI: 10.1371/journal.pone.0241886

[30]

Özalp O, İlgüy S, Atalay E, et al. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation. Int Ophthalmol. 2022;42(1):147–156. DOI: 10.1007/s10792-021-02009-3

[31]

Özalp O., İlgüy S., Atalay E., et al. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation // Int Ophthalmol. 2022. Vol. 42, No. 1. P. 147–156. DOI: 10.1007/s10792-021-02009-3

[32]

Melamed S. Aqueous drainage implants. Thomas JV, et al editors. Glaucoma surgery. Saint Louis: Mosby, 1992. P. 83–95.

[33]

Melamed S. Aqueous drainage implants. Glaucoma surgery / Ed. by J.V. Thomas, et al. Saint Louis: Mosby, 1992. P. 83–95.

[34]

Ritch R, Liebmann JM, Krupin T. Reoperations using setons. Ed. by Spaeth GL, et al. Current therapy in ophthalmic surgery. Toronto: Decker, 1989. P. 208–211.

[35]

Ritch R., Liebmann J.M., Krupin T. Reoperations using setons. Current therapy in ophthalmic surgery / Ed. by G.L. Spaeth, et al. Toronto: Decker, 1989. P. 208–211.

[36]

Sofinski SJ, Thomas JV, Simmons RJ. Filtering bleb revision techniques. Ed. by Thomas JV, et al. Glaucoma surgery. Saint Louis: Mosby, 1992. P. 75–82.

[37]

Sofinski S.J., Thomas J.V., Simmons R.J. Filtering bleb revision techniques. Glaucoma surgery / Ed. by J.V. Thomas, et al. Saint Louis: Mosby, 1992. P. 75–82.

[38]

Leuenberger EU, Grosskreutz CL, Walton DS, Pasquale LR. Advances in aqueous shunting procedures. Int Ophthalmol Clin. 1999;39(1):139–153. DOI: 10.1097/00004397-199903910-00013

[39]

Leuenberger E.U., Grosskreutz C.L., Walton D.S., Pasquale L.R. Advances in aqueous shunting procedures // Int Ophthalmol Clin. 1999. Vol. 39, No. 1. P. 139–153. DOI: 10.1097/00004397-199903910-00013

[40]

Terminologiya i rukovodstvo po glaukome. 4nd edition. Moscow: Oftal’mologiya, 2019.

[41]

Терминология и руководство по глаукоме. 4-е изд. Москва: Офтальмология, 2019.

[42]

Oblovatskaya ES, Nikolaenko VP. Ahmed valve implant and its place in the surgical treatment of glaucoma. National Journal glaucoma. 2022;21(2):35–41. (In Russ.) DOI: 10.53432/2078-4104-2022-21-2-35-41

[43]

Обловацкая Е.С., Николаенко В.П. Место дренажа Ахмеда в хирургии глаукомы // Национальный журнал глаукома. 2022. T. 21, № 2. C. 35–41. DOI: 10.53432/2078-4104-2022-21-2-35-41

[44]

Antonova AV, Nikolaenko VP, Brzheskiy VV. Realization of a cascade treatment algorithm for glaucoma in St. Petersburg. Russian Journal of Clinical Ophthalmology. 2021;21(3):123–128. (In Russ.) DOI: 10.32364/2311-7729-2021-21-3-123-128

[45]

Антонова А.В., Николаенко В.П., Бржеский В.В. Реализация «каскадного» алгоритма лечения глаукомы в Санкт-Петербурге // Клиническая офтальмология. 2021. T. 21, № 3. C. 123–128. DOI: 10.32364/2311-7729-2021-21-3-123-128

[46]

Аntonova АV, Nikolaenko VP, Brzheskiy VV, Vuks AJ. Factors influencing the effectiveness of trabeculectomy: following materials of the City Multidisciplinary Hospital No. 2. Ophthalmology Reports. 2022;15(4):35–44. (In Russ.) DOI: 10.17816/OV159363

[47]

Антонова А.В., Николаенко В.П., Бржеский В.В., Вукс А.Я. Факторы, снижающие эффективность синустрабекулэктомии: по материалам Санкт-Петербургского городского офтальмологического центра // Офтальмологические ведомости. 2022. Т. 15, № 4. С. 35–44. DOI: 10.17816/OV159363

[48]

Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol. 2000;130(3): 267–273. DOI: 10.1016/s0002-9394(00)00473-6

[49]

Wilson M.R., Mendis U., Smith S.D., Paliwal A. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial // Am J Ophthalmol. 2000. Vol. 130, No. 3. P. 267–273. DOI: 10.1016/s0002-9394(00)00473-6

[50]

Wilson MR, Mendis U, Paliwal A, Haynatzka V. Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol. 2003;136(3):464–470. DOI: 10.1016/s0002-9394(03)00239-3

[51]

Wilson M.R., Mendis U., Paliwal A., Haynatzka V. Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy // Am J Ophthalmol. 2003. Vol. 136, No. 3. P. 464–470. DOI: 10.1016/s0002-9394(03)00239-3

[52]

Park IK, Chun YS, Kim KG, et al. New clinical grading scales and objective measurement for conjunctival injection. Invest Ophthalmol Vis Sci. 2013;54(8):5249–5257. DOI:10.1167/iovs.12-10678

[53]

Park I.K., Chun Y.S., Kim K.G., et al. New clinical grading scales and objective measurement for conjunctival injection // Invest Ophthalmol Vis Sci. 2013. Vol. 54, No. 8. P. 5249–5257. DOI:10.1167/iovs.12-10678

[54]

Erichev VP, Filippova OM, Lovpache DzhN, Vasilenkova LV. Sindrom “sukhogo glaza” i mestnaya gipotenzivnaya terapiya glaukomy. Glaukoma. 2002;(2):40–42. (In Russ.)

[55]

Еричев В.П., Филиппова О.М., Ловпаче Дж.Н., Василенкова Л.В. Синдром «сухого глаза» и местная гипотензивная терапия глаукомы // Глаукома. 2002. № 2. С. 40–42.

[56]

Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009;25(2):113–119. DOI: 10.1089/jop.2008. 0098

[57]

Epstein S.P., Ahdoot M., Marcus E., Asbell P.A. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells // J Ocul Pharmacol Ther. 2009. Vol. 25, No. 2. P. 113–119. DOI: 10.1089/jop.2008. 0098

[58]

Rossi GC, Pasinetti GM, Scudeller L, et al. Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients. Eur J Ophthalmol. 2013;23(3):296–302. DOI: 10.5301/ejo.5000220

[59]

Rossi G.C., Pasinetti G.M., Scudeller L., et al. Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients // Eur J Ophthalmol. 2013. Vol. 23, No. 3. Р. 296–302. DOI: 10.5301/ejo.5000220

[60]

Boimer C, Birt CM. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma. 2013;22(9):730–735. DOI: 10.1097/IJG.0b013e31825af67d

[61]

Boimer C., Birt C.M. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study // J Glaucoma. 2013. Vol. 22, No. 9. P. 730–735. DOI: 10.1097/IJG.0b013e31825af67d

[62]

Brzheskiy VV, Popov VYu, Kalinina IV, et al. Efficacy of 0.01 % dexamethasone solution in comprehensive therapy of dry eye disease. Ophthalmology Reports. 2016;9(3):32–44. (In Russ.) DOI: 10.17816/OV9332-44

[63]

Бржеский В.В., Попов В.Ю., Калинина И.В., и др. Эффективность 0,01 % раствора дексаметазона в комплексной терапии больных с синдромом «сухого глаза» // Офтальмологические ведомости. 2016. Т. 9, № 3. C. 32–44. DOI: 10.17816/OV9332-44

[64]

Taniguchi J, Sharma A. Fluorometholone modulates gene expression of ocular surface mucins. Acta Ophthalmol. 2019;97(8): e1082–e1088. DOI: 10.1111/aos.14113

[65]

Taniguchi J., Sharma A. Fluorometholone modulates gene expression of ocular surface mucins // Acta Ophthalmol. 2019. Vol. 97, No. 8. P. e1082–e1088. DOI: 10.1111/aos.14113

[66]

Baudouin C, Nordmann J-P, Denis P, et al. Efficacy of indomethacin 0.1 % and fluorometholone 0.1 % on conjunctival inflammation following chronic application of antiglaucomatous drugs. Graefes Arch Clin Exp Ophthalmol. 2002;240(11):929–935. DOI: 10.1007/s00417-002-0581-9

[67]

Baudouin C., Nordmann J.-P., Denis P., et al. Efficacy of indomethacin 0.1 % and fluorometholone 0.1 % on conjunctival inflammation following chronic application of antiglaucomatous drugs // Graefes Arch Clin Exp Ophthalmol. 2002. Vol. 240, No. 11. P. 929–935. DOI: 10.1007/s00417-002-0581-9

[68]

Chamard C, Larrieu S, Baudouin C, et al. Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008–2016. Acta Ophthalmol. 2020;98(7): e876–e881. DOI: 10.1111/aos.14410

[69]

Chamard C., Larrieu S., Baudouin C., et al. Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008–2016 // Acta Ophthalmol. 2020. Vol. 98, No.7. P. e876–e881. DOI: 10.1111/aos.14410

[70]

Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society. J Glaucoma. 2017;26(8):687–693. DOI: 10.1097/IJG.0000000000000720

[71]

Vinod K., Gedde S.J., Feuer W.J., et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society // J Glaucoma. 2017. Vol. 26, No. 8. P. 687–693. DOI: 10.1097/IJG.0000000000000720

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

61

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/